- Report
- October 2024
- 197 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- May 2024
- 230 Pages
Global
From €2248EUR$2,290USD£1,870GBP
- Report
- November 2024
- 196 Pages
Global
From €4860EUR$4,950USD£4,041GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2577EUR$2,625USD£2,143GBP
€3681EUR$3,750USD£3,062GBP
- Report
- February 2024
- 80 Pages
Europe
From €4663EUR$4,750USD£3,878GBP
- Report
- February 2024
- 90 Pages
Global
From €4663EUR$4,750USD£3,878GBP
- Report
- June 2024
Global
From €4860EUR$4,950USD£4,041GBP
- Report
- October 2024
- 190 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- October 2024
- 196 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- October 2024
- 181 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- October 2024
- 190 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- October 2024
- 190 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- October 2024
- 192 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- March 2024
- 150 Pages
Global
From €5841EUR$5,950USD£4,858GBP
- Report
- March 2024
- 134 Pages
Global
From €5841EUR$5,950USD£4,858GBP
- Report
- November 2023
- 180 Pages
Global
From €5841EUR$5,950USD£4,858GBP
- Report
- September 2024
- 110 Pages
Global
From €5841EUR$5,950USD£4,858GBP
- Report
- July 2024
- 159 Pages
Global
From €5841EUR$5,950USD£4,858GBP
- Report
- October 2024
- 194 Pages
Global
From €3480EUR$3,545USD£2,894GBP
€3867EUR$3,939USD£3,216GBP
- Report
- September 2024
- 175 Pages
Global
From €4909EUR$5,000USD£4,082GBP
The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more